Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedservRegisMAL:MDS 43 Cash Ratio is 0.62 as of Dec. 2025, which is 19% below its 10-year median of 0.77. GuruFocus rates MAL:MDS with a GF Score™ of 43/100 and a GF Value™ of €0.93 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 979 Oil & Gas companies, MedservRegis ranks better than 59.75% on this metric.
MedservRegis has a Cash Ratio of 0.62. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for MedservRegis's Cash Ratio or its related term are showing as below:
MAL:MDS'
s Cash Ratio Range Over the Past 10 Years
Min: 0.31 Med: 0.77 Max: 5.74
Current: 0.62
During the past 13 years, MedservRegis's highest Cash Ratio was 5.74. The lowest was 0.31. And the median was 0.77.
MAL:MDS's Cash Ratio is ranked better than 59.75% of 979
companies
in the Oil & Gas industry
Industry Median: 0.45
vs MAL:MDS: 0.62
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
MedservRegis Cash Ratio Related Terms
MedservRegis Cash Ratio Historical Data
* Premium members only.
The historical data trend for MedservRegis's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Oil & Gas Equipment & Services subindustry, MedservRegis's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedservRegis Cash Ratio vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, MedservRegis's Cash Ratio distribution charts can be found below:
* The bar in red indicates where MedservRegis's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedservRegis (MAL:MDS) has a Cash Ratio of 0.62 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on MedservRegis and its competitors. This is 19% below median its historical median of 0.77. Over the past decade, MedservRegis' Cash Ratio has ranged from 0.31 to 5.74. According to the industry distribution chart, MedservRegis ranks #394 out of 979 companies in the Oil & Gas industry, placing it in the top 40.2%.
Is MedservRegis' Cash Ratio too high?
MedservRegis' current Cash Ratio of 0.62 is 19% below median its 10-year median of 0.77. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 5.74. The Oil & Gas industry median Cash Ratio is 0.45. MedservRegis' value of 0.62 is 37.8% above this industry median. Based on the distribution chart, MedservRegis ranks #394 out of 979 companies in the Oil & Gas industry, which is above the industry midpoint. Overall, MedservRegis has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MedservRegis' Cash Ratio compare to SLB and BKR?
According to the Oil & Gas industry distribution chart, MedservRegis ranks #394 out of 979 companies for Cash Ratio. This puts MedservRegis in the upper half of its industry. The industry median Cash Ratio is 0.45. MedservRegis' value of 0.62 is 37.8% above this benchmark. Historically, MedservRegis' own Cash Ratio has ranged from 0.31 to 5.74 over the past decade. While the company's 10-year median is 0.77 vs. the industry median of 0.45, MedservRegis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for an Oil & Gas company?
The median Cash Ratio among Oil & Gas companies is 0.45, based on 979 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedservRegis's current Cash Ratio of 0.62 is 37.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on MedservRegis and its competitors. For the Oil & Gas industry, the median Cash Ratio is 0.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedservRegis's current Cash Ratio is 0.62, which is 19% below median its own 10-year median of 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedservRegis stock overvalued right now?
Based on GuruFocus' analysis, MedservRegis (MAL:MDS) is currently considered Possible Value Trap. The stock's GF Value™ is €0.93, compared to a current price of €0.65 — trading 30.1% below its estimated fair value. The current Cash Ratio is 0.62, which is 19% below median its 10-year median of 0.77 and 37.8% above the Oil & Gas industry median of 0.45. MedservRegis' overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For MedservRegis (MAL:MDS), the current Cash Ratio is 0.62 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedservRegis (MAL:MDS) Overvalued in 2026?
Based on GuruFocus' analysis, MedservRegis stock appears to be undervalued.
The current stock price of €0.65 is trading 30.1% below its estimated GF Value™ of €0.93.
GuruFocus considers MedservRegis to be Possible Value Trap.
Key valuation signals for MAL:MDS:
Cash Ratio: 0.62 (19% below median its 10-year median of 0.77)
GF Value™: €0.93 vs. price of €0.65 (30.1% below fair value)
Industry Position: 37.8% above the Oil & Gas median (#394 of 979)
No single metric tells the full story. See the MAL:MDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedservRegis PLC is engaged in providing shore-based logistics to the offshore oil and gas industry and engineering and supply chain management for oil country tubular goods (OCTG) to support the onshore oil and gas industry. Its segment includes Integrated logistics support services; Oil country tubular goods; Trading activity and Photovoltaic farms. The company generates maximum revenue from the Integrated logistics support services segment, that Includes the provision of comprehensive logistical support services to the offshore oil and gas industry from the group's bases in Malta, Cyprus, Egypt, South America, and Africa.
43GF Score
Get the complete analysis for MAL:MDS
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAL:MDS has been successfully added to your 
